University of Texas at Arlington research projects contributed $59 million to the national economy in 2024—an increase of 39% from 2023, according to a new report from the Institute for Research on Innovation and Science (IRIS). UTA has invested heavily in research infrastructure, purchasing cutting-edge scientific equipment and technology, such as North Texas’ most advanced gene sequencer and a super-sensitive magnetic resonance imaging machine for the Clinical Imaging Research Center. The funds also support collaboration with other research organizations. 

Neglected Tropical Diseases (NTDs) remain a significant health burden in tropical and subtropical regions, with limited treatment options and diagnostic capabilities. These diseases are often neglected in research and policy, yet they contribute to high mortality and morbidity worldwide. Nanotechnology, particularly the conjugation of nanomaterials with drugs, presents an innovative approach to improving both the diagnosis and treatment of these diseases. Nanomaterials have unique properties that allow for enhanced drug delivery, reduced toxicity, and more precise targeting, making them a promising tool in the fight against NTDs.